Larisa H Cavallari Selected Research

Larisa H Cavallari Research Topics

Disease

14	Heart Failure 01/2021 - 06/2004
8	Hemorrhage 03/2022 - 08/2011
6	Myocardial Infarction 03/2022 - 11/2004
5	Pain (Aches) 02/2022 - 01/2018
5	Hypertension (High Blood Pressure) 01/2022 - 11/2004
5	Stroke (Strokes) 01/2018 - 05/2006
4	Acute Coronary Syndrome 03/2022 - 01/2017
4	Ischemic Stroke 01/2022 - 05/2006
4	Chronic Pain 12/2021 - 01/2018
3	Thrombosis (Thrombus) 03/2022 - 01/2022
3	Neoplasms (Cancer) 01/2018 - 08/2012
3	Drug-Related Side Effects and Adverse Reactions 12/2017 - 08/2012
3	Fibrosis (Cirrhosis) 09/2016 - 09/2007
3	Atrial Fibrillation 09/2015 - 01/2013
2	Unstable Angina 01/2022 - 01/2022
2	Gastroesophageal Reflux (GERD) 12/2021 - 01/2021
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2021 - 12/2017
2	Infections 01/2021 - 11/2018
2	Body Weight (Weight, Body) 01/2019 - 01/2015
2	Invasive Fungal Infections 11/2018 - 01/2017
2	Muscular Diseases (Myopathy) 03/2016 - 08/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2015 - 08/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2013 - 06/2009
1	Opioid-Related Disorders (Opiate Addiction) 02/2022
1	Diabetes Mellitus 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Diastolic Heart Failure 12/2021
1	Epilepsy (Aura) 01/2021
1	Duodenal Ulcer (Curling's Ulcer) 01/2021
1	Esophagitis 01/2021
1	Postoperative Pain 01/2021
1	Critical Illness (Critically Ill) 11/2018
1	Aspergillosis 11/2018
1	Vascular Remodeling 04/2018
1	Pulmonary Hypertension 04/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Cancer Pain 01/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2017

Drug/Important Bio-Agent (IBA)

9	Spironolactone (Aldactone)FDA LinkGeneric 12/2021 - 06/2004
9	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 05/2009
8	Clopidogrel (Plavix)FDA Link 03/2022 - 08/2012
6	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 02/2022 - 07/2009
6	Opioid Analgesics (Opioids)IBA 02/2022 - 01/2018
6	AldosteroneIBA 12/2021 - 11/2004
5	Cytochrome P-450 CYP2C19IBA 01/2022 - 01/2017
5	Mineralocorticoid Receptor AntagonistsIBA 01/2020 - 11/2004
4	Pharmaceutical PreparationsIBA 01/2021 - 08/2012
4	Cytochrome P-450 CYP2C9IBA 01/2020 - 12/2011
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 05/2006
4	PotassiumIBA 09/2013 - 06/2004
3	Prasugrel Hydrochloride FDA Link 03/2022 - 01/2020
3	TicagrelorIBA 03/2022 - 01/2020
3	omega-Chloroacetophenone (Mace)IBA 03/2022 - 01/2018
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 12/2021 - 09/2008
3	CollagenIBA 01/2017 - 06/2007
2	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 12/2021 - 01/2013
2	Proton Pump InhibitorsIBA 12/2021 - 01/2021
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2021 - 08/2011
2	Morphine (MS Contin)FDA LinkGeneric 01/2021 - 07/2009
2	Carbamazepine (Tegretol)FDA LinkGeneric 01/2021 - 12/2017
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021 - 07/2009
2	HLA-B Antigens (HLA-B)IBA 01/2021 - 12/2017
2	Codeine (Codeine Phosphate)FDA LinkGeneric 01/2019 - 07/2009
2	Voriconazole (Vfend)FDA LinkGeneric 11/2018 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 09/2016 - 09/2007
2	procollagen Type III-N-terminal peptide (PIIP)IBA 09/2016 - 09/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2016 - 08/2012
2	ProcollagenIBA 09/2007 - 06/2007
1	insulin receptor-related receptor (IRR)IBA 03/2022
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 02/2022
1	Analgesics (Analgesic Drugs)IBA 02/2022
1	TabletsIBA 01/2022
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2022
1	Ondansetron (Zofran)FDA LinkGeneric 12/2021
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	Opiate AlkaloidsIBA 12/2021
1	AcidsIBA 01/2021
1	IsoenzymesIBA 01/2021
1	Tramadol (K315)FDA LinkGeneric 01/2019
1	CreatinineIBA 01/2019
1	Pantoprazole (Protonix)FDA LinkGeneric 11/2018
1	ORALIT (ORS)IBA 10/2018
1	Hemoglobins (Hemoglobin)IBA 10/2018
1	Biological ProductsIBA 04/2018
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2018
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 04/2018
1	2-mercaptopurineIBA 01/2018
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 01/2018
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2018
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2018
1	Celecoxib (Celebrex)FDA Link 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2017

Therapy/Procedure

20	Therapeutics 03/2022 - 06/2004
4	Stents 03/2022 - 01/2018
4	Percutaneous Coronary Intervention 01/2022 - 03/2016
2	Pain Management 02/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2018 - 08/2012
2	Precision Medicine 01/2018 - 07/2013
1	Blood Transfusion (Blood Transfusions) 10/2018